When Should PSC Patients Have Gallbladder Polyps Removed?
At a Glance
Because Primary Sclerosing Cholangitis (PSC) increases the risk of gallbladder cancer, doctors recommend removing the gallbladder for much smaller polyps—often starting at 8 millimeters—compared to the general population. Rapid growth or polyps of any size may also warrant surgery.
In this answer
5 sections
If you have Primary Sclerosing Cholangitis (PSC) and your doctor recommends removing your gallbladder because of a small polyp, it is natural to feel alarmed. In the general public, small polyps are very common and usually left alone. However, doctors treat gallbladder polyps differently in PSC patients because the condition carries a significantly higher risk of gallbladder cancer [1][2]. While a 5-millimeter polyp might just be watched in someone without liver disease, major medical guidelines recommend proactively removing the gallbladder (cholecystectomy) in PSC patients [1][3]. This approach aims to safely remove the polyp before it has the chance to become cancerous.
Why the Rules Are Different for PSC
In the general population, gallbladder polyps are relatively common and usually harmless. Doctors typically only recommend surgery if a polyp grows larger than 10 millimeters [4][5].
However, PSC is a recognized high-risk factor for biliary tract and gallbladder malignancies [6][7]. Research shows that when gallbladder polyps are found in people with PSC, they are much more likely to be malignant (cancerous) or pre-cancerous [1][8]. Because of this elevated risk, the standard rules do not apply, and international guidelines mandate a much lower threshold for surgical intervention [8][9].
Current Size Thresholds and Guidelines
The exact size that triggers a recommendation for surgery can depend on your specific medical situation, but the threshold is always lower than for the general public:
- The 8-Millimeter Threshold: Many liver experts and major guidelines, including the AASLD and EASL, recommend removing the gallbladder if a polyp reaches 8 millimeters [2][3].
- The 6-to-9 Millimeter Range: Some European guidelines advise that surgery should be considered for polyps measuring between 6 and 9 millimeters, provided the patient is healthy enough for surgery [9][10].
- Rapid Growth or Any Size: Historically, and in some current international guidelines, doctors suggest removing the gallbladder for a polyp of any size in a PSC patient due to the high risk [8]. Today, many doctors also look closely at whether a small polyp is growing quickly between scans, which is a strong warning sign that warrants immediate removal [1][11].
Balancing Cancer Risk with Surgery Risks
While removing the gallbladder is the best way to prevent cancer, it is not the right choice for every PSC patient. The decision must be personalized by weighing the size and growth of the polyp against your overall liver health [2].
If your PSC has progressed to advanced liver disease (such as cirrhosis, which is severe scarring of the liver), abdominal surgery becomes exceptionally dangerous. In these cases, the risks of the surgery itself might outweigh the risk of the polyp becoming cancerous [12][13]. This is why your doctor will carefully evaluate your liver health before recommending surgery.
How You Are Monitored
Because gallbladder polyps cannot be safely biopsied while still inside the body, doctors rely on imaging to monitor them. If you have PSC, clinical practice guidelines recommend routine surveillance imaging—usually an abdominal ultrasound, CT scan, or MRI—every 6 to 12 months [2][14]. Note that for a gallbladder ultrasound, you will typically need to fast for several hours beforehand so the gallbladder is full and easier to see.
If a very tiny polyp (for example, 3 millimeters) is found, your doctor might recommend repeating the ultrasound in 3 to 6 months to check for growth before jumping straight to surgery [15][1].
What Gallbladder Removal Means for You
Since PSC already affects how bile flows through your liver, a common concern is how removing your gallbladder (which stores bile) will impact your digestion. Fortunately, your liver will continue to produce bile to help digest fats. Because the surgery is usually performed through small incisions (laparoscopically), recovery is often straightforward, though some patients temporarily need to eat smaller, less fatty meals as their body adjusts. Most importantly, your care team will help you manage any digestive changes and ensure the surgery is only performed if your liver is healthy enough to handle it [2][12].
Common questions in this guide
Why are gallbladder polyps treated differently if I have PSC?
At what size does a gallbladder polyp need to be removed in PSC?
How often should my gallbladder be checked if I have PSC?
What if I have advanced liver disease and a gallbladder polyp?
Will I have trouble digesting food after my gallbladder is removed?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact size of my polyp, and how does it compare to previous scans?
- 2.Given my current liver health and PSC stage, am I a safe candidate for gallbladder surgery?
- 3.If we decide to remove my gallbladder, what changes can I expect to my daily diet and digestion?
- 4.Is my polyp showing any mass-like features or rapid growth that would make immediate surgery urgent?
- 5.How will my cancer screening and imaging plan change after my gallbladder is gone?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps.
van Erp LW, Cunningham M, Narasimman M, et al.
Liver international : official journal of the International Association for the Study of the Liver 2020; (40(2)):382-392 doi:10.1111/liv.14326.
PMID: 31823479 - 2
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL, Lim JK, Lindor KD
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019; (17(12)):2416-2422 doi:10.1016/j.cgh.2019.07.011.
PMID: 31306801 - 3
Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis.
Altenmüller J, Wiegard C, Sebode M, et al.
Liver international : official journal of the International Association for the Study of the Liver 2025; (45(9)):e70312 doi:10.1111/liv.70312.
PMID: 40856347 - 4
Revised Guidelines for the Treatment and Follow-Up of Gallbladder Polyps Do Not Reduce Unwarranted Cholecystectomies: Results of the POLYP Study.
van Dooren M, de Savornin Lohman EAJ, van der Bilt J, et al.
United European gastroenterology journal 2025; (13(7)):1133-1140 doi:10.1002/ueg2.70057.
PMID: 40697033 - 5
Society of Radiologists in Ultrasound Consensus Conference Recommendations for Incidental Gallbladder Polyp Management: Interreader Agreement Among 10 Radiologists.
Anderson MA, Mercaldo S, Cao J, et al.
AJR. American journal of roentgenology 2024; (222(5)):e2330720 doi:10.2214/AJR.23.30720.
PMID: 38353447 - 6
Biliary Tract Malignancies Related to Gallbladder Polyps, Primary Sclerosing Cholangitis, and Choledochal Cysts.
Zia HA, Siddiqui UD
Clinical liver disease 2021; (18(2)):85-89 doi:10.1002/cld.1101.
PMID: 34584674 - 7
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.
Catanzaro E, Gringeri E, Burra P, Gambato M
Cancers 2023; (15(20)) doi:10.3390/cancers15204947.
PMID: 37894314 - 8
Risk assessment of gallbladder cancer in patients with primary sclerosing cholangitis and gallbladder polyps: a systematic review.
Grikyte I, Ignatavicius P
Langenbeck's archives of surgery 2025; (410(1)):216 doi:10.1007/s00423-025-03678-9.
PMID: 40632214 - 9
Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE.
Foley KG, Lahaye MJ, Thoeni RF, et al.
European radiology 2022; (32(5)):3358-3368 doi:10.1007/s00330-021-08384-w.
PMID: 34918177 - 10
[Recent Updates on Management and Follow-up of Gallbladder Polyps].
Son JH
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2023; (81(5)):197-202 doi:10.4166/kjg.2023.038.
PMID: 37226819 - 11
The management of gallbladder polyps.
Valibouze C, El Amrani M, Truant S, et al.
Journal of visceral surgery 2020; (157(5)):410-417 doi:10.1016/j.jviscsurg.2020.04.008.
PMID: 32473822 - 12
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.
Holmer M, Ingre M, Färkkilä M, et al.
Hepatology (Baltimore, Md.) 2026; (83(1)):21-29 doi:10.1097/HEP.0000000000001351.
PMID: 40238209 - 13
Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.
Tabibian JH, Ali AH, Lindor KD
Gastroenterology & hepatology 2018; (14(7)):427-432.
PMID: 30166959 - 14
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C, Friis-Liby I, Rorsman F, et al.
Journal of hepatology 2023; (78(3)):604-613 doi:10.1016/j.jhep.2022.11.011.
PMID: 36410555 - 15
Survey uncovering variations in the management of primary sclerosing cholangitis across Europe.
Eliasson J, Lo B, Schramm C, et al.
JHEP reports : innovation in hepatology 2022; (4(11)):100553 doi:10.1016/j.jhepr.2022.100553.
PMID: 36164416
This page explains gallbladder polyp guidelines in PSC for informational purposes only. Always consult your hepatologist, gastroenterologist, or surgeon regarding your specific liver health and treatment options.
Get notified when new evidence is published on Primary sclerosing cholangitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.